Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Cancers|June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
The Lancet. Oncology|June 29, 2026
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trialGiulio Francolini, Vanessa Di Cataldo, Saverio Caini, et al.
La Radiologia Medica|March 5, 2022
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysisGiulio Francolini, Barbara Alicja Jereczek-Fossa, Vanessa Di Cataldo, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
World Journal of Urology|March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter studyLuca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
Blood Advances|March 1, 2021
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemiaAntonio Pierini, Loredana Ruggeri, Alessandra Carotti, et al.
European Urology Oncology|February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter SeriesLudwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2022
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensusThomas Zilli, Vérane Achard, Alan Dal Pra, et al.
Prostate Cancer and Prostatic Diseases|February 19, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo, et al.
European Urology Oncology|April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective StudyNicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
Pageof 9